TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Pharmaust Limited ( (AU:NUZ) ) has issued an announcement.
Neurizon Therapeutics Limited has announced the application for the quotation of 150,000 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code NUZ. This move is part of the company’s strategy to enhance its capital structure and market presence, potentially impacting its operations and positioning within the industry.
The most recent analyst rating on (AU:NUZ) stock is a Buy with a A$0.56 price target. To see the full list of analyst forecasts on Pharmaust Limited stock, see the AU:NUZ Stock Forecast page.
More about Pharmaust Limited
Average Trading Volume: 775,672
Technical Sentiment Signal: Sell
Current Market Cap: A$58.8M
Find detailed analytics on NUZ stock on TipRanks’ Stock Analysis page.